Singapore insurers to review critical illness definitions under MAS-backed framework

Singapore insurers to review critical illness definitions under MAS-backed framework
Critical illness review ahead

Singapore's life insurance sector is set to revisit how severe stage critical illness policies define certain covered conditions as treatment standards evolve. The planned review in 2027 may shift some definitions away from specified surgical procedures toward the underlying disease and its severity, with potential implications for coverage scope and premiums.

Highlights

  • Life Insurance Association, Singapore will begin a 2027 review of its Critical Illness Framework definitions to reflect evolving diagnosis and treatment standards.
  • Chairman of MAS Gan Kim Yong stated that current severe stage critical illness policies rely on established procedures as objective indicators for claim eligibility and payout triggers.
  • In the 2027 review, LIA may shift critical illness definitions to focus less on specified procedures and more on underlying disease severity, affecting only new products.

2027 review of critical illness definitions

As reported by Monetary Authority of Singapore, the Life Insurance Association, Singapore periodically reviews and updates definitions in its Critical Illness Framework to reflect changes in how critical illnesses are diagnosed and treated.

In a written parliamentary reply, Chairman of MAS Gan Kim Yong said severe stage critical illness policies are designed to provide lump-sum payouts to help policyholders manage the financial impact of serious illness, rather than reimburse the cost of treatment or procedures. Some definitions therefore rely on established treatment procedures as objective indicators of disease severity, recovery time and resulting financial impact.

In its next review commencing in 2027, LIA will explore whether definitions for certain medical conditions and diseases can place less reliance on specified procedures and more on the underlying disease and its severity. Any revisions would apply to new products sold.

Our earlier article on Tune Protect’s FY2025–FY2026 performance explained how the insurer returned to profitability in FY2025 but faced renewed pressure in 1H FY2026 from weaker travel demand, lower investment income and foreign-exchange swings. We also noted that airline seat-capacity cuts and broader market uncertainty were pushing the group to diversify beyond travel insurance to protect future revenue streams.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.